Anti-tumor necrosis factor-α therapy may not be safe during pregnancy in women with inflammatory bowel disease: an updated meta-analysis and systematic review
Abstract Background Inflammatory Bowel Disease (IBD) affects reproductive-aged women. Active disease can lead to decreased fertility. Although the vast majority of international guidelines recommend for the continuation of anti-TNF-α during pregnancy, recent studies have raised concerns about the sa...
Saved in:
Main Authors: | Wei Huang (Author), Xinxing Zhang (Author), Li Zhang (Author), Xiaosong Dai (Author), Heping Chen (Author), Qin Xie (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review: Local Tumor Necrosis Factor-α Inhibition in Inflammatory Bowel Disease
by: Bahez Gareb, et al.
Published: (2020) -
Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor
by: Cristiano Pagnini, et al.
Published: (2019) -
Intra-articular therapy with tumor necrosis factor-α antagonists: an update
by: S. Bello, et al.
Published: (2014) -
Intracolic ultrasound molecular imaging: a novel method for assessing colonic tumor necrosis factor-α expression in inflammatory bowel disease
by: Xiaoyan Miao, et al.
Published: (2021) -
Tumor necrosis factor alpha (TNFα)-binding imprinted polymers. A non-systemic therapeutic approach for inflammatory bowel diseases
by: Rina Arad Yellin, et al.
Published: (2023)